Despite barriers to patients' access to neurovascular treatments, improving health care infrastructure, growing demand, and clinical data supporting the endovascular approach over surgical interventions for treating neurovascular diseases will support procedure volume growth in Asia Pacific countries, resulting in strong market growth through 2027.
This Medtech 360 Report provides high-level market metrics for Neurovascular devices in Asia Pacific countries, including country-level data for major countries and aggregate data for the rest of Asia Pacific, across a 10-year period.
- Neurovascular Devices - Market Insights - Asia Pacific (Supplemental)
Author(s): Sangeetha Iyer, Pharm.D
Sangeetha Iyer is an analyst within the Cardiovascular Medtech Insights team at Decision Resource Group, specializing in structural heart closure and vascular access device markerts across the Asia Pacific region, as well as medical device pricing and regulations in China and Japan. Sangeetha has represnted India at the European Society of Cardiology confrerence in Greece(2016) and Sweden(2017), where her research poster was awarded the top prize. Sangeetha holds a Doctor of Pharmacy degree from the Manipal Academy of Higher Education. Follow Sangeetha on twitter: @Slyer_DRG